Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif

被引:350
作者
Saha, Supriya K.
Pietras, Eric M.
He, Jeannie Q.
Kang, Jason R.
Liu, Su-Yang
Oganesyan, Gagik
Shahangian, Arash
Zarnegar, Brian
Shiba, Travis L.
Wang, Yao
Cheng, Genhong
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Med Scientist Training Program, Los Angeles, CA USA
[3] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China
关键词
Cardif; TRAF; interacting motif; TRAF3; type I interferon; virus;
D O I
10.1038/sj.emboj.7601220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon recognition of viral infection, RIG-I and Helicard recruit a newly identified adapter termed Cardif, which induces type I interferon (IFN)-mediated antiviral responses through an unknown mechanism. Here, we demonstrate that TRAF3, like Cardif, is required for type I interferon production in response to intracellular double-stranded RNA. Cardif-mediated IFN alpha induction occurs through a direct interaction between the TRAF domain of TRAF3 and a TRAF-interaction motif (TIM) within Cardif. Interestingly, while the entire N-terminus of TRAF3 was functionally interchangeable with that of TRAF5, the TRAF domain of TRAF3 was not. Our data suggest that this distinction is due to an inability of the TRAF domain of TRAF5 to bind the TIM of Cardif. Finally, we show that preventing association of TRAF3 with this TIM by mutating two critical amino acids in the TRAF domain also abolishes TRAF3-dependent IFN production following viral infection. Thus, our findings suggest that the direct and specific interaction between the TRAF domain of TRAF3 and the TIM of Cardif is required for optimal Cardif-mediated antiviral responses.
引用
收藏
页码:3257 / 3263
页数:7
相关论文
共 17 条
[1]   The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter [J].
Andrejeva, J ;
Childs, KS ;
Young, DF ;
Carlos, TS ;
Stock, N ;
Goodbourn, S ;
Randall, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17264-17269
[2]   The role of Toll-like receptors in the host response to viruses [J].
Bowie, AG ;
Haga, IR .
MOLECULAR IMMUNOLOGY, 2005, 42 (08) :859-867
[3]   TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-kappa B activation [J].
Cheng, GH ;
Baltimore, D .
GENES & DEVELOPMENT, 1996, 10 (08) :963-973
[4]   IRF3 mediates a TLR3/TLR4-specific antiviral gene program [J].
Doyle, SE ;
Vaidya, SA ;
O'Connell, R ;
Dadgostar, H ;
Dempsey, PW ;
Wu, TT ;
Rao, G ;
Sun, R ;
Haberland, ME ;
Modlin, RL ;
Cheng, G .
IMMUNITY, 2002, 17 (03) :251-263
[5]   Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 [J].
Häcker, H ;
Redecke, V ;
Blagoev, B ;
Kratchmarova, I ;
Hsu, LC ;
Wang, GG ;
Kamps, MP ;
Raz, E ;
Wagner, H ;
Häcker, G ;
Mann, M ;
Karin, M .
NATURE, 2006, 439 (7073) :204-207
[6]   Cell type-specific involvement of RIG-I in antiviral response [J].
Kato, H ;
Sato, S ;
Yoneyama, M ;
Yamamoto, M ;
Uematsu, S ;
Matsui, K ;
Tsujimura, T ;
Takeda, K ;
Fujita, T ;
Takeuchi, O ;
Akira, S .
IMMUNITY, 2005, 23 (01) :19-28
[7]   IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction [J].
Kawai, T ;
Takahashi, K ;
Sato, S ;
Coban, C ;
Kumar, H ;
Kato, H ;
Ishii, KJ ;
Takeuchi, O ;
Akira, S .
NATURE IMMUNOLOGY, 2005, 6 (10) :981-988
[8]   TLR signaling [J].
Kawai, T ;
Akira, S .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (05) :816-825
[9]   Downstream regulator TANK binds to the CD40 recognition site on TRAF3 [J].
Li, CL ;
Ni, CZ ;
Havert, ML ;
Cabezas, E ;
He, J ;
Kaiser, D ;
Reed, JC ;
Satterthwait, AC ;
Cheng, GH ;
Ely, KR .
STRUCTURE, 2002, 10 (03) :403-411
[10]   Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus [J].
Meylan, E ;
Curran, J ;
Hofmann, K ;
Moradpour, D ;
Binder, M ;
Bartenschlager, R ;
Tschopp, R .
NATURE, 2005, 437 (7062) :1167-1172